These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

139 related articles for article (PubMed ID: 15240585)

  • 1. Editorial: The determination of circulating 25-hydroxyvitamin D: no easy task.
    Hollis BW
    J Clin Endocrinol Metab; 2004 Jul; 89(7):3149-51. PubMed ID: 15240585
    [No Abstract]   [Full Text] [Related]  

  • 2. Assay variation confounds the diagnosis of hypovitaminosis D: a call for standardization.
    Binkley N; Krueger D; Cowgill CS; Plum L; Lake E; Hansen KE; DeLuca HF; Drezner MK
    J Clin Endocrinol Metab; 2004 Jul; 89(7):3152-7. PubMed ID: 15240586
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The future of "vitamin D", i.e. 25-hydroxyvitamin D, testing.
    Vieth R
    Clin Biochem; 2013 Feb; 46(3):189. PubMed ID: 23298561
    [No Abstract]   [Full Text] [Related]  

  • 4. Methodological issues in assessing plasma 25-hydroxyvitamin D concentration in newborn infants.
    Gallo S; Comeau K; Agellon S; Vanstone C; Sharma A; Jones G; L'abbé M; Khamessan A; Weiler H; Rodd C
    Bone; 2014 Apr; 61():186-90. PubMed ID: 24473373
    [TBL] [Abstract][Full Text] [Related]  

  • 5. 25-hydroxyvitamin D Correlation with Prolactin Levels and Adenoma Size in Female Patients with Newly Diagnosed Prolactin Secreting Adenoma.
    Aboelnaga MM; Abdullah N; El Shaer M
    Endocr Metab Immune Disord Drug Targets; 2017; 17(3):219-225. PubMed ID: 28595559
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Determination of vitamin D and its metabolites.
    Farrell CJ; Herrmann M
    Best Pract Res Clin Endocrinol Metab; 2013 Oct; 27(5):675-88. PubMed ID: 24094638
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Statins and vitamin D : editorial to: "increased levels of 25 hydroxyvitamin D and 1,25-dihydroxyvitamin D after rosuvastatin treatment: a novel pleiotropic effect of statins?" by Bunyamin Yavuz et al.
    Grimes DS
    Cardiovasc Drugs Ther; 2009 Aug; 23(4):261-2. PubMed ID: 19618258
    [No Abstract]   [Full Text] [Related]  

  • 8. The link between obesity and low circulating 25-hydroxyvitamin D concentrations: considerations and implications.
    Earthman CP; Beckman LM; Masodkar K; Sibley SD
    Int J Obes (Lond); 2012 Mar; 36(3):387-96. PubMed ID: 21694701
    [TBL] [Abstract][Full Text] [Related]  

  • 9. First 25-hydroxyvitamin D assay for general chemistry analyzers.
    Saida FB; Chen X; Tran K; Dou C; Yuan C
    Expert Rev Mol Diagn; 2015 Mar; 15(3):313-23. PubMed ID: 25434745
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Meta-analysis of circulating 25-hydroxyvitamin D levels and risk of cardiovascular and all-cause mortality in elderly population.
    Fan H; Yu W; Cao H; Li J; Liu B; Wang J; Shao Y; Fan Y; Yang J; Zhang Q; Hu X
    Int J Cardiol; 2014 Oct; 176(3):1025-9. PubMed ID: 25129266
    [No Abstract]   [Full Text] [Related]  

  • 11. The value of physiologic vitamin D as a biomarker of dementia.
    Buell JS; Tucker KL
    Drugs Today (Barc); 2011 Mar; 47(3):223-31. PubMed ID: 21494700
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Requirement of 25-hydroxyvitamin D in prevention of osteoporosis based on a pathophysiological perspective].
    Tsugawa N
    Clin Calcium; 2006 Jul; 16(7):1189-94. PubMed ID: 16816480
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A fast and simple method for simultaneous measurements of 25(OH)D, 24,25(OH)
    Fabregat-Cabello N; Farre-Segura J; Huyghebaert L; Peeters S; Le Goff C; Souberbielle JC; Cavalier É
    Clin Chim Acta; 2017 Oct; 473():116-123. PubMed ID: 28842174
    [TBL] [Abstract][Full Text] [Related]  

  • 14. 25-hydroxyvitamin D, vitamin D receptor gene polymorphisms, and severity of Parkinson's disease.
    Suzuki M; Yoshioka M; Hashimoto M; Murakami M; Kawasaki K; Noya M; Takahashi D; Urashima M
    Mov Disord; 2012 Feb; 27(2):264-71. PubMed ID: 22213340
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Circulating vitamin D-binding protein and free 25-hydroxyvitamin D concentrations in patients with melanoma: A case-control study.
    Navarrete-Dechent C; Del Puerto C; Molgó M; González S; Pérez-Mateluna G; Uribe P; Camargo CA; Borzutzky A
    J Am Acad Dermatol; 2017 Sep; 77(3):575-577. PubMed ID: 28807113
    [No Abstract]   [Full Text] [Related]  

  • 16. Analytical Bias in the Measurement of Serum 25-Hydroxyvitamin D Concentrations Impairs Assessment of Vitamin D Status in Clinical and Research Settings.
    Black LJ; Anderson D; Clarke MW; Ponsonby AL; Lucas RM;
    PLoS One; 2015; 10(8):e0135478. PubMed ID: 26266807
    [TBL] [Abstract][Full Text] [Related]  

  • 17. 25-hydroxyvitamin D measurement, 2009: a review for clinicians.
    Binkley N; Krueger D; Lensmeyer G
    J Clin Densitom; 2009; 12(4):417-27. PubMed ID: 19734080
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Serum 25-hydroxyvitamin D level and acute-phase reaction following initial intravenous bisphosphonate.
    Srivastava T; Dai H; Haney CJ; Alon US
    J Bone Miner Res; 2011 Feb; 26(2):437-8. PubMed ID: 21254232
    [No Abstract]   [Full Text] [Related]  

  • 19. Serum 25-hydroxyvitamin D, non-alcoholic fatty liver disease and type 2 diabetes.
    Afarideh M; Ghajar A; Noshad S; Saadat M; Khajeh E; Esteghamati A
    Nutr Metab Cardiovasc Dis; 2017 Jan; 27(1):93-95. PubMed ID: 27986351
    [No Abstract]   [Full Text] [Related]  

  • 20. Assessment of vitamin D status and definition of a normal circulating range of 25-hydroxyvitamin D.
    Hollis BW
    Curr Opin Endocrinol Diabetes Obes; 2008 Dec; 15(6):489-94. PubMed ID: 18971676
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.